Phaedra

Pulmonary Hypertension and associated Right Heart Failure: breaking the vicious circle

Menu

Skip to content
  • Home
  • About
  • Partners
  • Meetings
  • News
  • Publications
  • Contact
  • Login
    • Logo/templates
    • Meetings
    • Official documents
    • Protocols
  • Follow us on Twitter

CVON 1 Valve Talent Call 2017-2018

Call for the 1Valve Talent Program 2017-2018 is open.
First close 1 Sep.YTP 2017-2018 CVON 1VALVE CALL

This entry was posted in Premature aging of the lung vasculature explains the progression of pulmonary arterial hypertension, and this ‘irreversible’ process can be reversed by a new anti-aging drug on July 21, 2017 by J.J.A. de Boer-Theirlynck.

Post navigation

← Call for 1Valve Talent Program 2017-2018 Young scientist fellowship to Babu Kurakula →

Project funded by:









Website by NOFUSS © 2014